Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer JMJ Piek, PJ Van Diest, RP Zweemer, JW Jansen, RJJ Poort‐Keesom, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 996 | 2001 |
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis JMJ Piek, RHM Verheijen, P Kenemans, LF Massuger, H Bulten, ... Gynecologic oncology 90 (2), 491, 2003 | 197 | 2003 |
Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause JMJ Piek, P Kenemans, RHM Verheijen American journal of obstetrics and gynecology 191 (3), 718-732, 2004 | 139 | 2004 |
Tubal ligation and risk of ovarian cancer JMJ Piek, PJ van Diest, RP Zweemer, P Kenemans, RHM Verheijen The Lancet 358 (9284), 844, 2001 | 116 | 2001 |
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation … MG Harmsen, M Arts-de Jong, N Hoogerbrugge, AHEM Maas, JB Prins, ... BMC cancer 15, 1-9, 2015 | 111 | 2015 |
Ovarian carcinogenesis: an alternative hypothesis JMJ Piek, PJ Van Diest, RHM Verheijen Ovarian Cancer: State of the Art and Future Directions in Translational …, 2008 | 104 | 2008 |
Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma AM Snijders, ME Nowee, J Fridlyand, JMJ Piek, JC Dorsman, AN Jain, ... Oncogene 22 (27), 4281-4286, 2003 | 93 | 2003 |
Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer GF Vercellino, JMJ Piek, A Schneider, C Köhler, M Mangler, D Speiser, ... Gynecologic oncology 126 (3), 325-329, 2012 | 83 | 2012 |
Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study JMJ Piek, B Torrenga, B Hermsen, RHM Verheijen, RP Zweemer, ... Familial cancer 2, 73-78, 2003 | 81 | 2003 |
Hysterectomy with opportunistic salpingectomy versus hysterectomy alone LAM Van Lieshout, MP Steenbeek, JA De Hullu, MC Vos, S Houterman, ... The Cochrane database of systematic reviews 2019 (8), 2019 | 64 | 2019 |
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition JMJ Piek, RHM Verheijen, FH Menko, APM Jongsma, J Weegenaar, ... Histopathology 43 (1), 26-32, 2003 | 50 | 2003 |
Detection and localization of early-and late-stage cancers using platelet RNA S GJG, M Arkani, E Post, M Antunes-Ferreira, S D’Ambrosi, DCL Vessies, ... Cancer Cell 40 (9), 999-1009. e6, 2022 | 41 | 2022 |
Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1/2 pathogenic variant carriers: a nonrandomized controlled trial MP Steenbeek, MG Harmsen, N Hoogerbrugge, MA de Jong, ... JAMA oncology 7 (8), 1203-1212, 2021 | 41 | 2021 |
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer APM Jongsma, JMJ Piek, RP Zweemer, RHM Verheijen, JWTK Gebbinck, ... Molecular Pathology 55 (5), 305, 2002 | 39 | 2002 |
Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer BBJ Hermsen, PJ Van Diest, J Berkhof, FH Menko, JJP Gille, JMJ Piek, ... International journal of cancer 119 (6), 1412-1418, 2006 | 38 | 2006 |
Opportunistic salpingectomy in women undergoing hysterectomy: results from the HYSTUB randomised controlled trial LAM Van Lieshout, B Pijlman, MC Vos, MJM de Groot, S Houterman, ... Maturitas 107, 1-6, 2018 | 36 | 2018 |
Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome J van de Lande, S von Mensdorff-Pouilly, RG Lettinga, JM Piek, ... International Journal of Gynecologic Cancer 22 (1), 2012 | 33 | 2012 |
Peritoneal carcinomatosis after risk‐reducing surgery in BRCA1/2 mutation carriers MG Harmsen, JMJ Piek, J Bulten, MJ Casey, TR Rebbeck, MJ Mourits, ... Cancer 124 (5), 952-959, 2018 | 31 | 2018 |
The work place educational climate in gynecological oncology fellowships across Europe: the impact of accreditation J Piek, M Bossart, K Boor, M Halaska, D Haidopoulos, I Zapardiel, ... International Journal of Gynecologic Cancer 25 (1), 2015 | 31 | 2015 |
Whole genome analysis of ovarian granulosa cell tumors reveals tumor heterogeneity and a high-grade TP53-specific subgroup J Roze, G Monroe, J Kutzera, J Groeneweg, E Stelloo, S Paijens, ... Cancers 12 (5), 1308, 2020 | 30 | 2020 |